Etiopathogenesis of Chronic Bronchitis: A Symptom-Based Correlation with Sūʿāl and Its Management in Unani Medicine
Abstract
Chronic bronchitis is a major phenotype of chronic obstructive pulmonary disease (COPD), characterized by a persistent productive cough and excessive mucus secretion resulting from chronic airway inflammation. In Unani medicine, the term Waram-i- shoab Muzmin has been used in later writings as a literal translation, though the clinical description more closely resembles Sūʿāl, particularly Sūʿāl Aṣlī mentioned in classical sources. The present review explores the etiopathogenesis, symptomatology, and management of chronic bronchitis in both modern and Unani frameworks. Modern medicine attributes its development mainly to cigarette smoking, air pollution, and oxidative stress, which trigger airway remodelling, mucus hypersecretion, and epithelial injury. Unani physicians described similar mechanisms in terms of Sū’-i-Mizāj, Waram, Yubūsat, and accumulation of Mawād-i-Fāsida, often precipitated by cold, dust, and irritants, especially in individuals of Balghamī Mizāj . Preventive strategies, lifestyle regulation, and holistic management form the core of Unani practice, including Ilāj bi’l-Tadbīr (regimenal therapy), Ilāj bi’l-Ghizā (dietotherapy), and Ilāj bi’l-Dawā (pharmacotherapy). Various single drugs such as Asl-us-Soos (Glycyrrhiza glabra), Arusa (Adhatoda vasica), Behidana (Cydonia oblonga), and compound formulations like Laʿūq-e-Sapistān and Joshānda-e-Munḍij are employed, along with preventive measures such as avoiding phlegm-producing foods and exposure to cold air. Importantly, recent clinical evidence has validated the efficacy of licorice-based formulations in chronic cough, further supporting the relevance of Unani interventions. These insights demonstrate that Unani intervention can be effectively applied in clinical practice as a complementary option, offering safer and more sustainable strategies for managing chronic bronchitis.
Keywords: Chronic bronchitis, COPD, Sūʿāl, Unani medicine, Etiopathogenesis
Keywords:
chronic bronchitis, COPD, Sūʿāl, Unani medicine, EtiopathogenesisDOI
https://doi.org/10.22270/jddt.v15i10.7404References
1. Mohan H. Textbook of pathology. 9th ed. Revised reprint. New Delhi: Jaypee Brothers Medical Publishers; 2024.
2. Green LK. Emphysema and diseases of large airways. In: Zander DS, Farver CF, editors. Pulmonary pathology. Foundations in Diagnostic Pathology Series. Churchill Livingstone; 2008. p. 416-33. https://doi.org/10.1016/B978-0-443-06741-9.50026-4 PMid:18692465 PMCid:PMC2602844
3. Gingo MR, Morris A, Crothers K. Human immunodeficiency virus-associated obstructive lung diseases. Clin Chest Med. 2013;34(2):273-82. https://doi.org/10.1016/j.ccm.2013.02.002 PMid:23702176 PMCid:PMC3690924
4. Kim V, Criner GJ. The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implications. Curr Opin Pulm Med. 2015;21(2):133-41. https://doi.org/10.1097/MCP.0000000000000145 PMid:25575367 PMCid:PMC4373868
5. Petty TL. The history of COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(1):3-14. doi:10.2147/copd.2006.1.1.3. https://doi.org/10.2147/copd.2006.1.1.3 PMid:18046898 PMCid:PMC2706597
6. Widysanto A, Goldin J, Mathew G. Chronic bronchitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.
7. Rycroft CE, Heyes A, Lanza L, Becker K. Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis. 2012;7:457-94. https://doi.org/10.2147/COPD.S32330 PMid:22927753 PMCid:PMC3422122
8. Jurjani I. Zakhira Khwarazm Shahi. Khan HH, translator. Vol. 6. New Delhi: Idara Kitab-ul-Shifa; 2010.
9. Akbar Arzani H. Tibb-e-Akbar. Deoband: Faisal Publications; [Y.N.M.].
10. Sina I. Al-Qanoon fi'l Tibb. Kantoori GH, translator. New Delhi: Idara Kitab-ul-Shifa; 2010.
11. Baghdadi IH. Kitabul Mukhtarat-fil-Tibb. Central Council for Research in Unani Medicine, translator. Vol. 1. New Delhi: CCRUM; 2005.
12. Meteran H, Thomsen SF, Hjelmborg J, Miller MR, Christensen K, Sigsgaard T, et al. Genetic factors explain half of the individual susceptibility to chronic bronchitis, airflow obstruction and COPD regardless of the spirometric definition: a nationwide twin study. Lung. 2025;203(1):70. https://doi.org/10.1007/s00408-025-00825-3 PMid:40579575 PMCid:PMC12204911
13. Raby KL, Michaeloudes C, Tonkin J, Chung KF, Bhavsar PK. Mechanisms of airway epithelial injury and abnormal repair in asthma and COPD. Front Immunol. 2023;14:1201658. https://doi.org/10.3389/fimmu.2023.1201658 PMid:37520564 PMCid:PMC10374037
14. Rahman I, Adcock IM. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J. 2006;28(1):219-42. https://doi.org/10.1183/09031936.06.00053805 PMid:16816350
15. Janciauskiene S. The beneficial effects of antioxidants in health and diseases. Chron Obstr Pulm Dis (Miami). 2020;7(3):182-202. https://doi.org/10.15326/jcopdf.7.3.2019.0152 PMid:32558487 PMCid:PMC7857719
16. Patel M, Khangoora V. A review of the pulmonary and health impact of hookah use. Ann Am Thorac Soc. 2019;16(11):1219-28. https://doi.org/10.1513/AnnalsATS.201902-129CME PMid:31091965
17. Pérez-Padilla R, Ramirez-Venegas A, Sansores-Martinez R. Clinical characteristics of patients with biomass smoke-associated COPD and chronic bronchitis, 2004-2014. Chron Obstr Pulm Dis (Miami). 2014;1(1):23-32. https://doi.org/10.15326/jcopdf.1.1.2013.0004 PMid:28848808 PMCid:PMC5559138
18. Khan MA. Akseer-e-Azam (Al-Akseer). New Delhi: Idara Kitab-us-Shifa; 2011.
19. Al-Qumri AMH. Ghina Muna (Tarjuma Minhaj al-'Ilaj). New Delhi: CCRUM; 2008.
20. Majoosi AHBA. Kamil-us-Sana. (Urdu transl. Hkm G.H. Kantoori). New Delhi: Idara Kitab-us-Shifa; 2010.
21. Calverley PM. Modern treatment of chronic obstructive pulmonary disease. Eur Respir J Suppl. 2001;34:60s-66s. https://doi.org/10.1183/09031936.01.00229801 PMid:12392036
22. Braman SS. Chronic cough due to chronic bronchitis: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl):104S-115S. https://doi.org/10.1378/chest.129.1_suppl.104S PMid:16428699 PMCid:PMC7094692
23. Shaddock E, Richards G. Pharmacological management of chronic obstructive pulmonary disease. S Afr Med J. 2015;105(9):790. https://doi.org/10.7196/SAMJnew.8426 PMid:26636171
24. Poole P, Black PN. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2010;(2):CD001287. https://doi.org/10.1002/14651858.CD001287.pub3
25. Najmul Ghani R. Khazain-ul-Advia. Vols. 1-4. New Delhi: Idara Kitab-us-Shifa; 2011.
26. Ghaemi H, Masoompour SM, Afsharypuor S, Mosaffa-Jahromi M, Pasalar M, Ahmadi F, et al. The effectiveness of a traditional Persian medicine preparation in the treatment of chronic cough: a randomized, double-blinded, placebo-controlled clinical trial. Complement Ther Med. 2020;49:102324. https://doi.org/10.1016/j.ctim.2020.102324 PMid:32147070
27. National Formulary of Unani Medicine. New Delhi: CCRUM; 2006.
28. Jabbari Sabbagh A, Mohammadian Rasanan F, Bahrami A, Minaie Zangii B, Aliasl J, Rambod M, et al. Acute cough management in Persian medicine. Galen Med J. 2020;9:e1854. https://doi.org/10.31661/gmj.v9i0.1854N PMid:34466601 PMCid:PMC8343586
29. Aslani MR, Abdollahi N, Matin S, Zakeri A, Ghobadi H. Effect of crocin of Crocus sativus L. on serum inflammatory markers (IL-6 and TNF-α) in chronic obstructive pulmonary disease patients: a randomised, double-blind, placebo-controlled trial. Br J Nutr. 2023;130(3):446-453. https://doi.org/10.1017/S0007114522003397 PMid:36628554
30. The Unani Pharmacopoeia of India. Vols. 1-6. New Delhi: Government of India; 2007.
31. Kabiruddin H. Al-Qarabadeen (Al-Qarabadin). 2nd ed. New Delhi: Central Council for Research in Unani Medicine (CCRUM); 2006.
Published
Abstract Display: 116 
PDF Downloads: 147 PDF Downloads: 26 How to Cite
Issue
Section
Copyright (c) 2025 Ansari Sabahat Mansoor , Abid Ali Ansari, Shaikh Mohd Razik , Nasreen Jahan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.